The -256T>C polymorphism in the apolipoprotein A-II gene promoter is associated with body mass index and food intake in the genetics of lipid lowering drugs and diet network study.

BACKGROUND Apolipoprotein A-II (APOA2) plays an ambiguous role in lipid metabolism, obesity, and atherosclerosis. METHODS We studied the association between a functional APOA2 promoter polymorphism (-265T>C) and plasma lipids (fasting and postprandial), anthropometric variables, and food intake in 514 men and 564 women who participated in the Genetics of Lipid Lowering Drugs and Diet Network (GOLDN) study. We obtained fasting and postprandial (after consuming a high-fat meal) measures. We measured lipoprotein particle concentrations by proton nuclear magnetic resonance spectroscopy and estimated dietary intake by use of a validated questionnaire. RESULTS We observed recessive effects for this polymorphism that were homogeneous by sex. Individuals homozygous for the -265C allele had statistically higher body mass index (BMI) than did carriers of the T allele. Consistently, after multivariate adjustment, the odds ratio for obesity in CC individuals compared with T allele carriers was 1.70 (95% CI 1.02-2.80, P = 0.039). Interestingly, total energy intake in CC individuals was statistically higher [mean (SE) 9371 (497) vs 8456 (413) kJ/d, P = 0.005] than in T allele carriers. Likewise, total fat and protein intakes (expressed in grams per day) were statistically higher in CC individuals (P = 0.002 and P = 0.005, respectively). After adjustment for energy, percentage of carbohydrate intake was statistically lower in CC individuals. These associations remained statistically significant even after adjustment for BMI. We found no associations with fasting lipids and only some associations with HDL subfraction distribution in the postprandial state. CONCLUSIONS The -265T>C polymorphism is consistently associated with food consumption and obesity, suggesting a new role for APOA2 in regulating dietary intake.

[1]  J. K. Dunn,et al.  Relation of triglyceride metabolism and coronary artery disease. Studies in the postprandial state. , 1992, Arteriosclerosis and thrombosis : a journal of vascular biology.

[2]  G. Siest,et al.  Association of a functional 5-HT transporter gene polymorphism with anorexia nervosa and food intake , 2001, Molecular Psychiatry.

[3]  Alberto Riva,et al.  MAPPER: a search engine for the computational identification of putative transcription factor binding sites in multiple genomes , 2005, BMC Bioinformatics.

[4]  J. Fruchart,et al.  Apolipoprotein A-II, HDL metabolism and atherosclerosis. , 2002, Atherosclerosis.

[5]  A. Hamsten,et al.  Human Evidence That the Apolipoprotein A-II Gene Is Implicated in Visceral Fat Accumulation and Metabolism of Triglyceride-Rich Lipoproteins , 2001, Circulation.

[6]  F. Blanco-Vaca,et al.  Role of apoA-II in lipid metabolism and atherosclerosis: advances in the study of an enigmatic protein. , 2001, Journal of lipid research.

[7]  M. Emi,et al.  Interaction between the LDL-receptor gene bearing a novel mutation and a variant in the apolipoprotein A-II promoter: molecular study in a 1135-member familial hypercholesterolemia kindred , 2002, Journal of Human Genetics.

[8]  A. Lusis,et al.  Overexpression of apolipoprotein AII in transgenic mice converts high density lipoproteins to proinflammatory particles. , 1997, The Journal of clinical investigation.

[9]  E. Rubin,et al.  Expression of human apolipoprotein A-II and its effect on high density lipoproteins in transgenic mice. , 1992, The Journal of biological chemistry.

[10]  C. Bouchard,et al.  The MspI polymorphism of the apolipoprotein A-II gene as a modulator of the dyslipidemic state found in visceral obesity. , 1997, Atherosclerosis.

[11]  P. Tso,et al.  Apolipoprotein A-IV, food intake, and obesity , 2004, Physiology & Behavior.

[12]  J. Scott,et al.  HIGH-DENSITY LIPOPROTEIN COMPOSITION IS ALTERED BY A COMMON DNA POLYMORPHISM ADJACENT TO APOPROTEIN AII GENE IN MAN , 1985, The Lancet.

[13]  G. Siest,et al.  Polymorphism of the 5-HT2A receptor gene and food intakes in children and adolescents: the Stanislas Family Study , 2005 .

[14]  Claude Bouchard,et al.  The Human Obesity Gene Map: The 2005 Update , 2006, Obesity research.

[15]  E. Boerwinkle,et al.  Sequence polymorphism at the human apolipoprotein AII gene (APOA2): unexpected deficit of variation in an African-American sample , 2002, Human Genetics.

[16]  D C Rao,et al.  NHLBI Family Heart Study: objectives and design. , 1996, American journal of epidemiology.

[17]  J. Cardelli,et al.  Increased apolipoprotein A-IV in rat mesenteric lymph after lipid meal acts as a physiological signal for satiation. , 1992, The American journal of physiology.

[18]  N. Cook,et al.  Non-HDL cholesterol, apolipoproteins A-I and B100, standard lipid measures, lipid ratios, and CRP as risk factors for cardiovascular disease in women. , 2005, JAMA.

[19]  J. Chambaz,et al.  Apolipoprotein A-II: beyond genetic associations with lipid disorders and insulin resistance , 2003, Current opinion in lipidology.

[20]  G. Luc,et al.  Decreased Susceptibility to Diet-Induced Atherosclerosis in Human Apolipoprotein A-II Transgenic Mice , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[21]  A. Lusis,et al.  Studies with apolipoprotein A-II transgenic mice indicate a role for HDLs in adiposity and insulin resistance. , 2001, Diabetes.

[22]  Hedrick Cc,et al.  Apolipoprotein A-II: a protein in search of a function. , 1994 .

[23]  R. Jandacek,et al.  Diurnal changes in intestinal apolipoprotein A-IV and its relation to food intake and corticosterone in rats. , 2005, American journal of physiology. Gastrointestinal and liver physiology.

[24]  Jan Karlsson,et al.  Genetic and environmental influences on eating behavior: the Swedish Young Male Twins Study. , 2005, The American journal of clinical nutrition.

[25]  J. Ordóñez‐Llanos,et al.  Human apolipoprotein A-II is a pro-atherogenic molecule when it is expressed in transgenic mice at a level similar to that in humans: evidence of a potentially relevant species-specific interaction with diet. , 1998, Journal of lipid research.

[26]  D. Midthune,et al.  Comparative validation of the Block, Willett, and National Cancer Institute food frequency questionnaires : the Eating at America's Table Study. , 2001, American journal of epidemiology.

[27]  C. Bouchard,et al.  A genome-wide linkage scan for dietary energy and nutrient intakes: the Health, Risk Factors, Exercise Training, and Genetics (HERITAGE) Family Study. , 2004, The American journal of clinical nutrition.

[28]  J. Lovejoy,et al.  Apolipoprotein A-II polymorphism and visceral adiposity in African-American and white women. , 2005, Obesity research.

[29]  J. Otvos,et al.  Measurement of lipoprotein subclass profiles by nuclear magnetic resonance spectroscopy. , 2002, Clinical laboratory.

[30]  William E Grizzle,et al.  Serum levels of an isoform of apolipoprotein A-II as a potential marker for prostate cancer. , 2005, Clinical cancer research : an official journal of the American Association for Cancer Research.

[31]  T. Bouchard,et al.  Genetic and environmental influences on self-reported diet: a reared-apart twin study , 1998, Physiology & Behavior.

[32]  L Wilhelmsen,et al.  Multivariate Analyses of Serum Apolipoproteins and Risk Factors in Relation to Acute Myocardial Infarction , 1981, Arteriosclerosis.

[33]  F. Blanco-Vaca,et al.  Apolipoprotein A-II, genetic variation on chromosome 1q21-q24, and disease susceptibility , 2004, Current opinion in lipidology.

[34]  G Siest,et al.  5-HT2A receptor gene polymorphism is associated with food and alcohol intake in obese people , 2000, International Journal of Obesity.

[35]  K. Niwa,et al.  Cellular growth under hydrostatic pressure using bovine aortic EC-SMC co-cultured ePTFE vascular graft. , 2005, Journal of Zhejiang University. Science. B.

[36]  C. Shelley,et al.  A DNA polymorphism of the apoprotein AII gene in hypertriglyceridaemia , 1986, Human Genetics.

[37]  J. Jobe,et al.  Cognitive research enhances accuracy of food frequency questionnaire reports: results of an experimental validation study. , 2002, Journal of the American Dietetic Association.

[38]  J. Buring,et al.  Decreased HDL2 and HDL3 Cholesterol, Apo A‐I and Apo A‐II, and Increased Risk of Myocardial Infarction , 1992, Circulation.

[39]  D. Arnett,et al.  Comparison of ultracentrifugation and nuclear magnetic resonance spectroscopy in the quantification of triglyceride-rich lipoproteins after an oral fat load. , 2004, Clinical chemistry.

[40]  A. Daluiski,et al.  Evidence for linkage of the apolipoprotein A-II locus to plasma apolipoprotein A-II and free fatty acid levels in mice and humans. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[41]  Melinda E. Lull,et al.  Apo-AII is an elevated biomarker of chronic non-human primate ethanol self-administration. , 2006, Alcohol and alcoholism.